Atorvastatin Calcium
Product Images NDC 67046-334

5 FDA label images from Coupler Enterprises · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 67046-334). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Coupler Enterprises, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure-01 (Figure 01)

Figure-01 (Figure 01)
A cumulative incidence line graph comparing atorvastatin and placebo over 3.5 years. The x-axis represents time in years, while the y-axis shows cumulative incidence percentage. Atorvastatin is shown with a solid line and placebo with a dotted line, indicating lower incidence in the atorvastatin group.*
FDA Label Image

Figure-02 (Figure 02)

Figure-02 (Figure 02)
A line graph comparing the cumulative hazard percentage over time between placebo and atorvastatin groups. The x-axis represents time in years up to four years of follow-up, while the y-axis shows the cumulative hazard percentage. The atorvastatin group consistently shows a lower cumulative hazard than the placebo group throughout the period.*
FDA Label Image

Figure-03 (Figure 03)

Figure-03 (Figure 03)
A line chart comparing the percentage of subjects experiencing a cardiovascular event over a 5-year period between Atorvastatin 10 mg and 80 mg doses. The x-axis shows time in years to the first major cardiovascular endpoint, and the y-axis shows the percentage of subjects. A hazard ratio (HR) of 0.78 with confidence interval (0.69-0.89) and a p-value of 0.0002 are displayed, indicating statistical results between the two doses.*
FDA Label Image

Atorv20 (Atorv20)

Atorv20 (Atorv20)
Label for Atorvastatin Calcium 20 mg tablets, package of 30, distributed by Coupler Enterprises. The label includes dosage form (tablets), strength (20 mg), quantity (30 tablets), and storage instructions at controlled room temperature (20-25°C). It also indicates the product is RX only with an expiration date of 12/31/2025, lot number placeholder (XXXX), and manufacturer listed as Cipla. The label features multiple barcodes and standard regulatory data.*
FDA Label Image

Chemical-structure (Chemical Structure)

Chemical-structure (Chemical Structure)
Chemical structure diagram of atorvastatin calcium showing its molecular components, including phenyl rings, hydroxyl groups, and calcium ions (Ca2+).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.